Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
Duphaston 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablet. A round, biconvex, scored, white film-coated tablet, one side with inscription ‘155’ on either side of the score. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film coated tablet contains 10 mg Dydrogesterone.
Excipients: each tablet contains 111.1 mg of lactose monohydrate.
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dehydroprogesterone |
Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone. |
| List of Excipients |
|---|
|
Core: Lactose Monohydrate Film Coating: Hypromellose |
Cartons of 42 or 60 blister packed tablets in Al/PVC blister strips.
Not all packs sizes may be marketed.
Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland
PA2010/010/001
Date of first authorisation: 28 January 1985
Date of last renewal: 28 January 2010
| Drug | Countries | |
|---|---|---|
| DUPHASTON | Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
